Company intelligence / Profile preview

Eversight

Ann Arbor, Michigan, United Stateseversightvision.org ↗

Ownership: Private
Development stage: Commercial

Overview

Eversight provides human corneal and ocular tissues for transplantation and research globally. Through partnerships such as with Emmecell, it supports the development of cell therapies that could dramatically expand access to sight-restoring treatments beyond traditional transplantation. In recent years, it has provided thousands of corneas annually for transplant worldwide and contributed to innovations in imaging, limbal stem cell procurement, and rare disease research.

Therapeutic areas: Rare DiseasesOphthalmology
Modalities: Cell therapy (via partnerships)Human tissue transplantationBiologic (corneal tissue)Device (imaging and software solutions for eye banking)
Industry: Contract Research Organization

Partnerships

Emmecell BiotechLighTopTech Corp.StatlinePhoenix Nest Inc.

Beyond the preview

Go deeper on Eversight.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eversight.

Explore the full profile